Cargando…
Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development
OBJECTIVE: Currently available measles vaccines are administered by subcutaneous injections and require reconstitution with a diluent and a cold chain, which is resource intensive and challenging to maintain. To overcome these challenges and potentially increase vaccination coverage, microneedle pat...
Autores principales: | Adhikari, Bishwa B., Goodson, James L., Chu, Susan Y., Rota, Paul A., Meltzer, Martin I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114202/ https://www.ncbi.nlm.nih.gov/pubmed/27696306 http://dx.doi.org/10.1007/s40268-016-0144-x |
Ejemplares similares
-
A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination
por: Prausnitz, Mark R, et al.
Publicado: (2020) -
Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children
por: Wong, Carlos, et al.
Publicado: (2016) -
Microneedle patches for vaccine delivery
por: Suh, Hyemee, et al.
Publicado: (2014) -
Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]
por: Adigweme, Ikechukwu, et al.
Publicado: (2022) -
Dissolving Microneedle Patches for Dermal Vaccination
por: Leone, M., et al.
Publicado: (2017)